Clinical Trial Data Transparency
Comparative Perspectives on
Context, Challenges & Opportunities

As of March 20th registration for the summer school has be postponed until further notice.  


A Summer School at Carleton University about clinical trial data transparency. Clinical trial data transparency refers to the extent to which clinical trial data is made publicly available, and the extent to which trial results are accurately reported so as to inform researchers and patients of the potential risks and benefits of pharmaceutical products. The Summer School will bring together academic experts, policymakers, public servants and healthcare professionals to discuss about the evolution of clinical trial data transparency, current challenges and opportunities, as well as tools and information to better access and navigate such data.

Clinical trial data transparency is of significant importance in ensuring the safety and effectiveness of pharmaceuticals. Various issues in the realm of clinical trial data transparency pose challenges for stakeholders including patients, physicians, researchers, policymakers, regulatory agencies, and academics. These issues include the sheer bulk of regulatory data, reporting biases that influence the selection and omission of certain information in academic journals, and the distortion of trial results. Participants will have the opportunity to engage in conversations centred on the importance of evidence-based medicine and decision making, the legal and ethical frameworks that inform current pharmaceutical regulations, as well as the broader political and social landscape of the pharmaceutical industry. The Summer School intends to shed light on the role of clinical trial data transparency in ensuring patient safety, shaping physician prescribing practices, and enabling patient and physician autonomy. 

The Summer School seeks an interdisciplinary audience of academic experts, students, policymakers, journalists, public servants and professionals in the healthcare field (i.e. physicians, health regulators, administrators, etc.) to participate and share their perspectives on clinical trial data transparency. Application forms must be filled out and submitted in order to participate. 

June 15th – June 19th, 2020

Carleton University; 1125 Colonel By Dr, Ottawa, ON K1S 5B6

     View Schedule >>  & Fees >> 

Professor Trudo Lemmens University of Toronto, Faculty of Law and the Dalla Lana School of Public Health
Dr. Till Bruckner TranspariMED
Dr. Sergio Sismondo Queen's University, Department of Philosophy
Mr. Terence Young Chair of Drug Safety Canada; Former MP for Oakville 2008-2015
Dr. John Abramson Harvard University
Dr. Jennifer Miller Yale University, School of Medicine
Mr. Paul Thacker Freelance Journalist
Dr. Courtney Davis King’s College (UK), Department of Global Health and Social Medicine
Dr. Peter Doshi University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research
Dr. Janice Graham Dalhousie University, Faculty of Medicine
Dr. Bryn Williams-Jones Université de Montréal, Bioethics Program at the School of Public Health
Professor Matthew Herder Dalhousie University, Schulich School of Law & Department of Pharmacology
Dr. Nav Persaud University of Toronto, Department of Family and Community Medicine
Dr. Joel Lexchin York University, Faculty of Health & University of Toronto, Faculty of Medicine

Workshop on public health reform

City University of London, 6 June 2022

white and brown labeled bottle


Photo by Jan Kopriva, Unsplash



Cannabis in Canada: A Primer. Part Four.
Cannabis in Canada: A Primer. Part Seven.
Cannabis in Canada: A Primer. Part Three.
False hope for new Canadians
A minimum threshold for effective cycling networks